-78%

est. 2Y upside i

HealthcareSeries C

The world's first digital clinic for substance use management

Rank

#4204

Sector

Digital Health / Behavioral Health

Est. Liquidity

~5Y

Data Quality

Data: Medium

Real clinical traction (3.4M lives, 100% retention) but murky equity picture: valuation undisclosed, revenue undisclosed, digital health headwinds.

Last updated: March 22, 2026

Bull (15%)+80%

Strategic acquirer (Optum/CVS) pays 4-5x rev at $600-800M.

Base (50%)-20%

Decelerating growth; acquisition near or below Series C implied val.

Bear (35%)-70%

Lyra/Optum expand; reimbursement compression; distressed.

Est. time to liquidity~4.5 years

Preference Stack Risk

high

$151M raised; valuation unknown — could be 38-50% of value.

Dilution Risk

moderate

Series C with 9-year history; mature cap table.

Secondary Liquidity

none

No secondary.

Questions to Ask at the Interview

Strategic questions based on Pelago's data — designed to show you've done your homework.

  • 1

    Valuation and cap table?

  • 2

    Activation rate from covered lives?

  • 3

    Revenue model: PEPM vs utilization?

Community

Valuation Sentiment

Our model estimates -78% upside. What do you think?

Anonymous. Do not share material non-public information.


Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.